Quantcast
  • E-mail
  • Print
  • Comment
  • Font Size
  • Digg
  • del.icio.us
  • Discuss article

OTN Appoints Kimberly A. Bergstrom, Pharm.D., As Chief Clinical Officer

Posted on: Friday, 9 December 2005, 09:00 CST

SOUTH SAN FRANCISCO, Calif., Dec. 9 /PRNewswire/ -- OTN (Oncology Therapeutics Network), a leading independent oncology services company, today announced the appointment of Kimberly A. Bergstrom, Pharm.D., as Chief Clinical Officer. Dr. Bergstrom has more than 20 years of healthcare experience, including 11 years of experience developing oncology clinical services and programs. At OTN, Dr. Bergstrom will develop and implement the clinical strategy for OTN's customer segments, including physicians, nurses, practice administrators, payors and manufacturers. Her responsibilities will include the development of clinical technology and infrastructure solutions for customers, clinical information and reporting services development, and clinical programs development, including advisory boards and medical education for OTN and Onmark, OTN's group purchasing organization (GPO).

"Kim brings to OTN a wealth of relevant experience in oncology and an unparalleled interest in clinical and quality-focused patient outcomes," said John Amos, President and CEO of OTN. "Her amazing vision and extensive expertise, especially in drug therapy use in the community-based oncology practice setting, will help us further our 'patient first' agenda by enhancing our clinical offerings."

Dr. Bergstrom joined OTN from the National Oncology Alliance (NOA), a GPO focused on community oncology, where she served as Vice President of Clinical Services and a member of the executive management team. During her tenure at NOA, she developed a complete set of clinical services offerings, programs and tools for community-based medical oncology practices.

"I'm excited to join the OTN team and to help the company leverage its outstanding technology platform to deliver clinical information, services and programs to customers. As oncology care continues to evolve, evidence- supported treatment decisions, outcomes capture and reporting, and clinical and business tools that drive efficiency will be critical to community oncologists' success," said Dr. Bergstrom.

Prior to joining NOA, Dr. Bergstrom held senior positions at First DataBank, a leading electronic drug database company, and YourDoctor.com, an internet-based healthcare portal for patients. Earlier, she spent five years with OnCare, where she developed cancer-specific treatment guidelines and clinical decision support tools, including chemotherapy ordering and scheduling software. As Vice President of Disease Management at OnCare, she was responsible for directing all clinical outcomes studies for community- based oncology practitioners, including those for breast, lung, colon, rectal, ovarian, head and neck cancers and supportive care therapies. She has also served as Director of Pharmaceutical Services at Mount Zion Medical Center of the University of California, San Francisco (UCSF).

Dr. Bergstrom received her Doctorate in Pharmacy degree from UCSF, where she also completed a clinical residency and specialty residency in pharmacy administration. She currently serves as an adjunct Assistant Clinical Professor at UCSF, School of Pharmacy.

About Onmark

Onmark, an OTN company, is a leading national group purchasing organization (GPO) for community oncology. Onmark is committed to helping practices extend and enhance the lives of cancer patients by providing the support that they need to prosper. Through strategic relationships with OTN, pharmaceutical companies and industry experts, Onmark provides its members with access to a full portfolio of contracts for oncology drugs and supplies, the most aggressive pricing available through OTN, as well as practice management tools and educational programs focusing on community oncology. For more information, please visit http://www.onmarkservices.com/.

About OTN

OTN is an industry-leading oncology services company that provides oncology drugs, supportive care products and related supplies to more than 2,400 office-based oncology practices in the United States, comprising more than 4,000 physicians. OTN was recognized as one of InformationWeek's top 500 companies in 2003 and 2004 and was recently honored with Frost & Sullivan's 2005 Customer Value Enhancement Award in recognition of its role in advancing cancer care in the community-based setting. OTN continues to develop innovative technology solutions to help oncology practices improve practice efficiency, minimize costs and maximize revenues. OTN is dedicated to helping community-based oncology practices extend and enhance the lives of people with cancer by offering the highest level of customer service and a knowledgeable support staff. For more information, please visit http://www.myotn.com/.

OTN

CONTACT: Jonathan Zalk of OTN, +1-650-871-3321, orjonathan.zalk@myotn.com; or Daryl Messinger of WeissComm Partners,+1-415-999-2361, or daryl@weisscommpartners.com, for OTN

Web site: http://www.myotn.com/


Source: PRNewswire

More News in this Category


Related Articles



Rating: 2.4 / 5 (10 votes)
Rate this article:
1/52/53/54/55/5

User Comments (0)

Comment on this article

Your Name
Text from the image
Comment
max 1200 chars
* All fields are required